HTLV-1-associated adult T cell leukemia/lymphoma in two patients from Bucharest, Romania

Leukemia

Volumn 10, Issue 8, 1996, Pages 1366-1369

  Veelken, H ^a   Kohler G ^a   Schneider, J ^a   Dierbach, H ^a   Mertelsmann, R ^a   Schaefer, H E ^a   Lubbert M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adult T cell leukemia; HTLV I; Lymphoma; Romania

Indexed keywords

ETOPOSIDE; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IFOSFAMIDE; METHOTREXATE; LEUKOCYTE ANTIGEN; PRIMER DNA; VIRUS DNA;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; HYPERCALCEMIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROMANIA; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR BIOPSY; VIRUS CARCINOGENESIS; BIOPSY; BLOOD; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; VIROLOGY;

ADULT; ANTIGENS, CD; BASE SEQUENCE; BIOPSY; DNA PRIMERS; DNA, VIRAL; FEMALE; HTLV-I ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; ROMANIA;

EID: 0029666140     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Maeda Y, Furukawa M, Takehara Y, Yoshimura K, Miyamoto K, Matsuura T, Morishima Y, Tajima K, Okochi K, Hinuma Y. Prevalence of possible acute T cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int J Cancer 1984; 33: 717-720.
2. Levine PK, Blattner WA, Clark J, Tarone R, Maloney EM, Murphy EM, Callo RC, Robert-Guroff M, Saxinger WC. Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer 1988; 42: 7-12.
3. Miyamoto Y, Yamaguchi K, Nishimura H, Takatsuki K, Morimatsu M, Yasaka T, Ohya I, Koga T. Familial adult T-cell leukemia. Cancer 1985; 55: 181-185.
4. Höllsberg P, Hafler DA. Pathogenesis of diseases induced by human lymphotropic virus type I infection. New Engl J Med 1993; 328: 1173-1182.
5. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994; 343: 213-216.
6. Tokudome S, Tokunaga O, Shimamoto Y, Miyamoto Y, Sumida I, Kikuchi M, Takeshita M, Ikeda T, Fujiwara K, Yoshihara M, Yanagawa T, Nishizumi M. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res 1989; 49: 226-228.
7. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA. Modelling the risk of adult T cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43: 250-253.
8. Yodoi J, Uchiyama T. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 1992; 13: 405-411.
9. Feuer G, Chen IS. Mechanisms of human T-cell leukemia virus-induced leukemogenesis. Biochim Biophys Acta 1992; 1114: 223-233.
10. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992; 79: 477-480.
11. Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 1992; 80: 3205-3216.
12. Shimoyama M and members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. Br J Haematol 1991; 79: 428-439.
13. Schaefer HE. Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis. Pathologe 1995; 16: 11-27.
14. Fujino R, Kawato K, Ikeda M, Miyakoshi K, Mizukoshi M, Imai J. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 1991; 82: 367-370.
15. Koeffler HP, Chen ISY, Golde DW. Characterization of a novel HTLV-infected cell line. Blood 1984; 64: 482-490.
16. Hall WW, Chunren RL, Schneewind O, Takahashi H, Kaplan MH, Röupe G, Vahlne A. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 1991; 253: 317-320.
17. Koppler H, Pfluger KH, Eschenbach I, Pfab R, Birkmann J, Zeller W, Holle R, Steinhauer UE, Gropp C, Oehl S et al. Randomized comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial. Ann Oncol 1994; 5: 49-55.
18. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic recovery after high-dose VP-16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
19. Rosenthal MA, Grigg AP, Sheridan WP. High-dose busulphan/cyclophosphamide for autologous bone marrow transplantation is associated with minimal non-hematopoietic toxicity. Leu Lymphoma 1994; 14: 279-283.
20. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gutterman J, Coltman C, Moon TE. Hydroxyldaunorubicin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484-1493.
21. Hoelzer D. Treatment of acute lymphoblastic leukemia. Semin Hematol 1994; 31: 1-15.
22. Paquet C, Babes VT, Drucker J, Senemaud B, Dobresco A. Viral hepatitis in Bucharest. Bull World Health Organ 1993; 71: 781-786.
23. Hersh BS, Popovici F, Jezek Z, Satten GA, Apetrei RC, Beldescu N, George JR, Shapiro CN, Gayle HD, Heymann DL. Risk factors for HIV infection among abandoned Romanian children. AIDS 1993; 7: 1617-1624.